Vir Biotechnology, Inc. (VIR) has already been able to initiate its late-stage ECLIPSE program, which is using the combination of monoclonal antibody tobevibart in combination with small interfering ...

For over a century, advances in science and technology have raised concerns spanning ethical, legal, safety, security, and environmental risks, often shaped by the type products, materials, knowledge, ...

SANTA ANA, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of ...

Of the nearly 400 million tons of plastic waste produced annually, about half ends up discarded, polluting landscapes and waterways worldwide. Developing sustainable ways to recover, break down and ...